Lipoprotein Lipase Deficiency
📧 Sign up to get email alerts when something new happens for Lipoprotein Lipase Deficiency.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2017-08-17Clinical Trial Update: Alipogene Tiparvovec for the Treatment of LPLD Patients [Phase 2]
A Phase 2 trial of alipogene tiparvovec for lipoprotein lipase deficiency was withdrawn from the study.
-
EMA withdrawal · 2012-04-20European Medicines Agency maintains recommendation not to grant a marketing authorisation for Glybera
The European Medicines Agency maintains its recommendation not to grant marketing authorisation for Glybera (alipogene mimutran) for lipopro…